Last year, Addyi—the first FDA-approved pill for women's low libido—launched in the U.S. The key question: does it actually work? Early clinical studies provide the first answers.
Women taking Addyi reported satisfying sex about once every two months more often than those on placebo—a modest increase. However, this comes with caveats: daily dosing is required, it acts on the brain, and alcohol must be avoided to prevent risks like high blood pressure and fainting. Addyi isn't available in the Netherlands yet, but is it worth pursuing?
Loes Jaspers, lead author of the peer-reviewed study and epidemiologist, recommends women with low libido consult their GP first, who may refer them to a sexologist for personalized care.
